CARA OVERSTREET: Open Payments
NPI 1114515699 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$829 in 36 payments from 14 companies in 2025. Trend: 2023 $494 · 2024 $733 · 2025 $829
Food & beverage: $828Education: $2
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $137 |
| Calliditas Therapeutics US Inc. | 3 | $93 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $84 |
| Novartis Pharmaceuticals Corporation | 4 | $81 |
| AKEBIA THERAPEUTICS INC | 3 | $77 |
| Ardelyx, Inc. | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 2 | $57 |
| Novo Nordisk Inc | 2 | $52 |
| Amgen Inc. | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
Products named: JYNARQUE, TARPEYO, Kerendia, Fabhalta, IBSRELA, FARXIGA, Auryxia, Ozempic.
Industry payments across GA — which companies pay providers there.
